These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21827571)

  • 1. Fibroblast growth factor receptor 4 Gly388 Arg polymorphism is not associated with pre-eclampsia in Turkish women.
    Gunes EG; Pinarbasi E
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1824-7. PubMed ID: 21827571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor gene +813CC polymorphism of foetus is associated with preterm labour but not with pre-eclampsia in Turkish pregnant women.
    Atis A; Oruc O; Aydin Y; Cetincelik U; Goker N
    Int J Immunogenet; 2012 Jun; 39(3):241-6. PubMed ID: 22257487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.
    Ho CK; Anwar S; Nanda J; Habib FK
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):94-6. PubMed ID: 19918264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of microsomal epoxide hydrolase gene polymorphism and pre-eclampsia in Turkish women.
    Pinarbasi E; Percin FE; Yilmaz M; Akgun E; Cetin M; Cetin A
    J Obstet Gynaecol Res; 2007 Feb; 33(1):32-7. PubMed ID: 17212663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal tumor necrosis factor receptor 2 gene variants associated with pre-eclampsia in Tunisian women.
    Said L; Faleh R; Smida S; Laajili H; Sakouhi M; Bel Hadj Jrad B
    J Obstet Gynaecol Res; 2013 Aug; 39(8):1301-7. PubMed ID: 23799986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between the CYP11B2 gene polymorphism and preeclampsia, eclampsia, and the HELLP syndrome in Turkish women.
    Percin FE; Cetin M; Pinarbasi E; Akgun E; Gurlek F; Cetin A
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):213-7. PubMed ID: 16303227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
    Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
    Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
    Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
    Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients.
    Spinola M; Leoni V; Pignatiello C; Conti B; Ravagnani F; Pastorino U; Dragani TA
    J Clin Oncol; 2005 Oct; 23(29):7307-11. PubMed ID: 16061909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
    Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
    Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of leptin level and leptin receptor gene polymorphisms with susceptibility to severe pre-eclampsia].
    Guan LX; Gao L; Gao Y; Li HB; Yu FF; Du XY; Jiang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Oct; 28(5):562-7. PubMed ID: 21983736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
    Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
    J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.
    da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B
    Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas.
    Mawrin C; Kirches E; Diete S; Wiedemann FR; Schneider T; Firsching R; Kropf S; Bogerts B; Vorwerk CK; Krüger S; Dietzmann K
    Cancer Lett; 2006 Aug; 239(2):239-45. PubMed ID: 16198476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
    Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
    Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
    Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
    J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia.
    Bányász I; Szabó S; Bokodi G; Vannay A; Vásárhelyi B; Szabó A; Tulassay T; Rigó J
    Mol Hum Reprod; 2006 Apr; 12(4):233-6. PubMed ID: 16517614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia.
    Vural P; Degirmencioglu S; Saral NY; Demirkan A; Akgul C; Yildirim G; Issever H; Eroglu H
    J Obstet Gynaecol Res; 2010 Feb; 36(1):64-71. PubMed ID: 20178529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
    Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
    Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.